Exenatide can reduce glucose independent of islet hormones or gastric emptying.
about
Incretins and the intensivist: what are they and what does an intensivist need to know about them?Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseNeonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats.Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemia.Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.Exenatide sensitizes insulin-mediated whole-body glucose disposal and promotes uptake of exogenous glucose by the liver.Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusEndogenously released GLP-1 is not sufficient to alter postprandial glucose regulation in the dogLong-term tolerance and efficacy of adjunctive exenatide therapy on glycaemic control and bodyweight in type 2 diabetes: a retrospective study from a specialist diabetes outpatient clinic.Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesisInhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dogInfluence of feeding a fish oil-containing diet to mature, overweight dogs: Effects on lipid metabolites, postprandial glycaemia and body weight.Influence of feeding a fish oil-containing diet to young, lean, adult dogs: effects on lipid metabolites, postprandial glycaemia and body weight.
P2860
Q26995464-3F7A1518-FF20-4C1E-9A82-6CCC70CBA478Q27027920-460ACD60-2E11-461D-BEE8-3D6B81EE5722Q33579205-8D169851-36E5-4667-891C-0AE039E862B7Q34355968-F0D5DEFB-F17C-48B3-8FF5-2C9F0EDBD816Q35640531-A99EA0FD-131A-4D9D-A6ED-FA8F2F1AEBB7Q37066877-DE11334C-31DA-4DEB-8972-528BFFAB08F6Q37141727-2AAABA8C-8FE4-48A7-889E-8CCD8AF9E697Q37726837-010E7908-21EA-48D0-A31D-14239AECDB77Q38216039-3840257B-EFE9-447D-90A4-44BC821CE70BQ42022343-8D0F2982-4DF5-4AC2-9D50-703FF4CDD2C7Q42140416-7332648F-05E9-444C-BC44-4C3DCA70C337Q47213541-9AB0AED1-FEAD-471F-A1AF-AF42A3602727Q47352585-06B63817-913E-45C3-9387-D1FE8CE1493E
P2860
Exenatide can reduce glucose independent of islet hormones or gastric emptying.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Exenatide can reduce glucose independent of islet hormones or gastric emptying.
@en
type
label
Exenatide can reduce glucose independent of islet hormones or gastric emptying.
@en
prefLabel
Exenatide can reduce glucose independent of islet hormones or gastric emptying.
@en
P2093
P2860
P1476
Exenatide can reduce glucose independent of islet hormones or gastric emptying.
@en
P2093
Darko Stefanovski
Richard N Bergman
Viorica Ionut
P2860
P304
P356
10.1152/AJPENDO.90222.2008
P577
2008-05-20T00:00:00Z